These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 4238087)

  • 21. Clonazepam and dithiaden in hyperkinetic children.
    Výborová L; Balastíková B; Drtílková I; Náhunek K
    Act Nerv Super (Praha); 1979 Oct; 21(3):155-6. PubMed ID: 574703
    [No Abstract]   [Full Text] [Related]  

  • 22. Roussy-Levy Syndrome with psychosis.
    Latimer PR; Braden DH
    Can Psychiatr Assoc J; 1975 Jun; 20(4):287-9. PubMed ID: 1182641
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical trial of jatamansone (syn: Valeranone) in hyperkinetic behaviour disorders.
    Gupta PD; Virmani V
    Neurol India; 1968; 16(4):168-73. PubMed ID: 4886500
    [No Abstract]   [Full Text] [Related]  

  • 24. Tetrabenazine therapy of pediatric hyperkinetic movement disorders.
    Jain S; Greene PE; Frucht SJ
    Mov Disord; 2006 Nov; 21(11):1966-72. PubMed ID: 16958131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predicting amphetamine response in hyperkinetic children by electronic pupillography.
    Knopp W; Arnold LE; Andras RL; Smeltzer DJ
    Pharmakopsychiatr Neuropsychopharmakol; 1973 May; 6(3):158-66. PubMed ID: 4795017
    [No Abstract]   [Full Text] [Related]  

  • 26. [Stimulants in the treatment of hyperkinetic behavior disorders].
    Barkai A
    Harefuah; 1971 Mar; 80(6):298-302. PubMed ID: 4946564
    [No Abstract]   [Full Text] [Related]  

  • 27. The paradoxical effects of CNS stimulants on hyperkinetic behavior.
    Millichap JG
    Int J Neurol; 1975; 10(1-4):241-51. PubMed ID: 1181313
    [No Abstract]   [Full Text] [Related]  

  • 28. Minimal brain dysfunctions in children.
    Peters JE
    Am Fam Physician; 1974 Jul; 10(1):115-23. PubMed ID: 4834966
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hyperkinetic syndrome in childhood].
    Padan J
    Dtsch Med Wochenschr; 1980 Aug; 105(33):1159-60. PubMed ID: 7449629
    [No Abstract]   [Full Text] [Related]  

  • 30. Proceedings: Controlled clinical comparative study of octoclothepin, propericiazine and placebo in hyperkinetic children.
    Výborová L; Náhunek K; Drilková I; Balasíková B; Misurec J
    Act Nerv Super (Praha); 1975; 17(4):209-10. PubMed ID: 3929
    [No Abstract]   [Full Text] [Related]  

  • 31. Anxious-depressed adults and problem children treated with thioridazine in private practice.
    Schweikart W
    Curr Ther Res Clin Exp; 1971 Mar; 13(3):162-8. PubMed ID: 4998287
    [No Abstract]   [Full Text] [Related]  

  • 32. Caffeine in the treatment of children with minimal brain dysfunction or hyperkinetic syndrome.
    Gross MD
    Psychosomatics; 1975; 16(1):26-7. PubMed ID: 1101283
    [No Abstract]   [Full Text] [Related]  

  • 33. [Thioridazine in nervous children].
    Claveau JC; Tremblay M; Larochelle J; Aubin G
    Union Med Can; 1968 Jun; 97(6):780-4. PubMed ID: 5758625
    [No Abstract]   [Full Text] [Related]  

  • 34. [The introduction into schooling of an educable cerebrally handicapped child].
    Aebi U
    Wien Med Wochenschr; 1978 Jan; 128(1):9-14. PubMed ID: 146315
    [No Abstract]   [Full Text] [Related]  

  • 35. Sedation of difficult-to-sedate children undergoing MR imaging: value of thioridazine as an adjunct to chloral hydrate.
    Greenberg SB; Faerber EN; Radke JL; Aspinall CL; Adams RC; Mercer-Wilson DD
    AJR Am J Roentgenol; 1994 Jul; 163(1):165-8. PubMed ID: 8010205
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of thioridazine, amphetamine and placebo on the hyperkinetic syndrome and cognitive area in mentally deficient children.
    Alexandris A; Lundell FW
    Can Med Assoc J; 1968 Jan; 98(2):92-6. PubMed ID: 4864657
    [No Abstract]   [Full Text] [Related]  

  • 37. Thioridazine in the management of organic behavior disturbances in children.
    Baldwin RW; Kenny TJ
    Curr Ther Res Clin Exp; 1966 Aug; 8(8):373-7. PubMed ID: 4958152
    [No Abstract]   [Full Text] [Related]  

  • 38. The effect of methylphenidate on sensory perception in varying degrees of hyperkinetic behaviour.
    Butter HJ; Lapierre YD
    Dis Nerv Syst; 1975 Jun; 36(6):286-8. PubMed ID: 1097220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Modification of hyperkinetic behavior by nortriptyline.
    Watter N; Dreifuss FE
    Va Med Mon (1918); 1973 Feb; 100(2):123-6. PubMed ID: 4683948
    [No Abstract]   [Full Text] [Related]  

  • 40. [Damage pattern in 419 handicapped children in one region].
    Krzyzanowski A; Jacoby R; Wilken H
    Zentralbl Gynakol; 1984; 106(8):506-11. PubMed ID: 6233827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.